Abacus FCF Advisors LLC

Position in LLY — ELI LILLY & Co

CIK 1604903 Orlando, FL

Position in LLY

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$15,921,235

+$13,742,099 QoQ

Shares Held

13,274

+227.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

2.97%

of 13F equity value

Holder Rank

#1,009

of 4,605 holders

Holding Since

Mar 2022

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Abacus FCF Advisors LLC holds $56,450,925 across 5 Drug Manufacturers - General names. LLY ranks #1 (28.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	13,274	$15,921,235
2	ABBV	AbbVie Inc.	58,634	$14,754,659
3	BMY	Bristol Myers Squibb Co	227,584	$13,113,390
4	GILD	Gilead Sciences, Inc.	59,974	$7,577,115
5	AMGN	Amgen Inc	14,041	$5,084,526

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15,921,235	13,274	+227.2%	Shares	Sole	2026-08-10
2023-09-30	$2,179,136	4,057	-2.7%	Shares	Sole	2023-10-10
2023-06-30	$1,954,708	4,168	-25.3%	Shares	Sole	2023-07-19
2023-03-31	$1,916,970	5,582	-8.5%	Shares	Sole	2023-04-19
2022-12-31	$2,231,624	6,100	-2.2%	Shares	Sole	2023-02-03
2022-09-30	$2,016,087	6,235	-6.7%	Shares	Sole	2022-10-12
2022-06-30	$2,167,477	6,685	-41.9%	Shares	Sole	2022-07-20
2022-03-31	$3,296,118	11,510	—	Shares	Sole	2022-04-28
No filing history on record for this holder in this stock.